Disclosed herein is an improved cost effective process for preparing Simvastatin of high yield and better purity. More specifically, the present invention discloses an improved process step of preparing Simvastatin cyclohexylamide phenyboronate from Lovastatin cyclohexylamide boronate with an optimized molar ratio o...
ABSTRACT
DICLOFENAC COMPOSITION
The present invention relates a composition comprising Diclofenac and salts thereof wherein Diclofenac or its slats are present in an amount of 25 - 200 mg. The composition is suitable for the parenteral administration through intramuscular, intravenous route; also for oral, derma...
The present invention relates to pharmaceutical compositions of various pharmaceutical actives, especially lyophilic and hydrophilic actives containing Diethylene glycol monoethyl ether or other alkyl derivatives thereof as a primary vehicle and/or to pharmaceutical compositions utilizing Diethylene glycol monoethyl...
ABSTRACT
“FULVESTRANT COMPOSITIONS”
The inventive subject matter provides ready to inject fulvestrant compositions with improved solubility and stability, and methods for preparing the same. Contemplated compositions include fulvestrant at a concentration of greater than 100 mg/ml, and maintain degradation of...
Disclosed herein is an improved cost-effective process for preparation of Simvastatin from Lovastatin using eco-friendly reagents resulting in pharmaceutically acceptable grade Simvastatin. More specifically disclosed is the route of synthesis from Lovastatin to Lovastatin cyclohexylamide phenylboronate and then to ...
The present invention relates to a novel process for isolation and recovery of compounds such as biosynthetically produced simvastatin in either lactone form or in the form of its acid salt in high yield and purity, from microbial fermentation broth and isolating the said statin from harvested microbial broth.
...
Disclosed herein is topical pharmaceutical composition comprising Lidocaine or its pharmaceutically acceptable salts in combination with one or more other local anesthetic agent(s) along with propellants, solvents and other pharmaceutically acceptable excipients useful for the treatment of premature ejaculation and ...
Disclosed herein is a sustained release pharmaceutical composition comprising therapeutically effective amount of muscle relaxant such as Thiocolchicoside or Cyclobenzaprine or its pharmaceutically acceptable salts alone or in combination, along with rate controlling polymer(s) and pharmaceutically acceptable excipi...
ABSTRACT
“DICLOFENAC COMPOSITIONS”
The present invention relates to stable, efficacious and safe aqueous injectable composition comprising about 75 mg/ml of Diclofenac or its pharmaceutically acceptable salt along with Glycine in preferably about 0.1%w/v to 2%w/v and other pharmaceutically acceptable with or w...
ABSTRACT
“PHARMACEUTICAL COMPOSITION OF CYCLOOXYGENASE – 2 INHIBITORS”
Present invention relates to aqueous compositions comprising cyclooxygenase-2 (COX-2) inhibitors, preferably Etoricoxib or Celecoxib or Valdecoxib or Paracoxib or salts thereof at least two solubilizers at 4.2% w/v to 19% w/v, preferably betw...
[Class : 5] Pharmaceutical And Veterinary Preparations, Sanitary Preparations For Medical Purposes, Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies, Dietary Supplements For Humans And Animals, Plasters, Disinfectants.
[Class : 5] Pharmaceutical And Veterinary Preparations, Sanitary Preparations For Medical Purposes, Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies, Dietary Supplements For Humans And Animals, Plasters, Disinfectants.
View +252 more Brands for Themis Medicare Limited.
Charges
501 Crore
18 October 2006
Union Bank Of India
3 Crore
26 July 2006
Union Bank Of India
23 Crore
12 July 2006
Union Bank Of India - Lead Bank Of Ubi Consortium
117 Crore
14 October 2005
Union Bank Of India
19 Crore
25 June 2004
Bank Of Baroda
36 Crore
12 May 2012
The Kapol Co-operative Bank Ltd.
4 Crore
21 June 2012
The Kapol Co-operative Bank Ltd.
80 Lak
14 July 2005
Idbi Bank Limited
8 Crore
14 July 2005
Industrial Development Bank Of India Limited
5 Crore
08 October 2018
Union Bank Of India
88 Crore
18 July 2018
Hdfc Bank Limited
17 Lak
18 July 2018
Hdfc Bank Limited
4 Lak
05 February 2018
Union Bank Of India
3 Crore
21 July 2017
Union Bank Of India
5 Crore
23 July 2015
The Zoroastrian Co-operative Bank Limited
5 Crore
25 March 2015
Union Bank Of India
10 Crore
29 June 2012
Union Bank Of India
32 Crore
06 January 2012
Union Bank Of India
2 Crore
05 January 2009
Union Bank Of India
19 Crore
05 January 2009
Union Bank Of India
1 Crore
11 January 2007
Union Bank Of India - Lead Bank Of Ubi Consortium
117 Crore
29 June 2021
Union Bank Of India
55 Lak
24 June 2021
Union Bank Of India
18 Lak
19 March 2021
Union Bank Of India
71 Lak
24 December 2020
Union Bank Of India
4 Crore
11 November 2020
Bank Of Baroda
3 Crore
31 October 2020
Union Bank Of India
1 Crore
27 October 2020
Hdfc Bank Limited
20 Lak
20 January 2020
Union Bank Of India
5 Crore
23 March 2020
Union Bank Of India
45 Crore
15 May 2020
Union Bank Of India
45 Crore
31 May 2022
Others
0
05 January 2022
Others
0
31 December 2021
Others
0
31 December 2021
Others
0
31 December 2021
Others
0
20 January 2020
Others
0
23 March 2020
Others
0
15 May 2020
Others
0
27 October 2020
Hdfc Bank Limited
0
11 November 2020
Others
0
24 December 2020
Others
0
18 July 2018
Hdfc Bank Limited
0
18 July 2018
Hdfc Bank Limited
0
05 February 2018
Others
0
19 March 2021
Others
0
29 June 2021
Others
0
24 June 2021
Others
0
08 October 2018
Others
0
14 October 2005
Union Bank Of India
0
26 July 2006
Union Bank Of India
0
25 June 2004
Bank Of Baroda
0
25 March 2015
Union Bank Of India
0
21 June 2012
The Kapol Co-operative Bank Ltd.
0
12 May 2012
The Kapol Co-operative Bank Ltd.
0
05 January 2009
Union Bank Of India
0
05 January 2009
Union Bank Of India
0
06 January 2012
Union Bank Of India
0
23 July 2015
The Zoroastrian Co-operative Bank Limited
0
14 July 2005
Idbi Bank Limited
0
31 October 2020
Others
0
14 July 2005
Industrial Development Bank Of India Limited
0
12 July 2006
Others
0
21 July 2017
Others
0
11 January 2007
Union Bank Of India - Lead Bank Of Ubi Consortium
0
18 October 2006
Union Bank Of India
0
29 June 2012
Union Bank Of India
0
31 May 2022
Others
0
05 January 2022
Others
0
31 December 2021
Others
0
31 December 2021
Others
0
31 December 2021
Others
0
20 January 2020
Others
0
23 March 2020
Others
0
15 May 2020
Others
0
27 October 2020
Hdfc Bank Limited
0
11 November 2020
Others
0
24 December 2020
Others
0
18 July 2018
Hdfc Bank Limited
0
18 July 2018
Hdfc Bank Limited
0
05 February 2018
Others
0
19 March 2021
Others
0
29 June 2021
Others
0
24 June 2021
Others
0
08 October 2018
Others
0
14 October 2005
Union Bank Of India
0
26 July 2006
Union Bank Of India
0
25 June 2004
Bank Of Baroda
0
25 March 2015
Union Bank Of India
0
21 June 2012
The Kapol Co-operative Bank Ltd.
0
12 May 2012
The Kapol Co-operative Bank Ltd.
0
05 January 2009
Union Bank Of India
0
05 January 2009
Union Bank Of India
0
06 January 2012
Union Bank Of India
0
23 July 2015
The Zoroastrian Co-operative Bank Limited
0
14 July 2005
Idbi Bank Limited
0
31 October 2020
Others
0
14 July 2005
Industrial Development Bank Of India Limited
0
12 July 2006
Others
0
21 July 2017
Others
0
11 January 2007
Union Bank Of India - Lead Bank Of Ubi Consortium
0
18 October 2006
Union Bank Of India
0
29 June 2012
Union Bank Of India
0
Documents
Form AOC-4(XBRL)-21082024_signed
Form MGT-15-05082024_signed
Optional Attachment-(1)-30072024
Form MSME FORM I-27052024_signed
Form MSME FORM I-05022024_signed
Form MSME FORM I-30012024
Form MSME FORM I-30012024_signed
Optional Attachment-(1)-14122023
Optional Attachment-(2)-14122023
Form Addendum to AOC-4 CSR-14122023_signed
Form MGT-7-04112023_signed
List of share holders, debenture holders;-02112023
Optional Attachment-(1)-02112023
Copy of MGT-8-02112023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-06102023
XBRL document in respect Consolidated financial statement-06102023
Form AOC-4(XBRL)-06102023_signed
Form MGT-7-23092023_signed
Form MGT-15-16092023_signed
Optional Attachment-(1)-15092023
Form MSME FORM I-28082023_signed
Form MSME FORM I-28042023_signed
Form MSME FORM I-23022023_signed
Optional Attachment-(1)-15112022
Copy of MGT-8-15112022
Form MGT-7-15112022
List of share holders, debenture holders;-15112022